trial · primary record
NNC9836-0001
Diabetes Mellitus, Type 2
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 121 |
| Primary completion | 2028-07-26 |
| Primary endpoint | Single ascending dose (SAD): Number of Treatment emergent adverse events (TEAEs) |
| Registry ID | NCT07896109 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:56.778Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07896109
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.